You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
ELOCTATE is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia A (congenital factor VIII deficiency) for:
- control and prevention of bleeding episodes
- routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- perioperative management (surgical prophylaxis).
ELOCTATE does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
ELOCTATE is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia A (congenital factor VIII deficiency) for:
- control and prevention of bleeding episodes
- routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- perioperative management (surgical prophylaxis).
ELOCTATE does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
ELOCTATE is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia A (congenital factor VIII deficiency) for:
- control and prevention of bleeding episodes
- routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- perioperative management (surgical prophylaxis).
ELOCTATE does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
ELOCTATE is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia A (congenital factor VIII deficiency) for:
- control and prevention of bleeding episodes
- routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- perioperative management (surgical prophylaxis).
ELOCTATE does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
ELOCTATE is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia A (congenital factor VIII deficiency) for:
- control and prevention of bleeding episodes
- routine prophylaxis to prevent or reduce the frequency of bleeding episodes
- perioperative management (surgical prophylaxis).
ELOCTATE does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
